David McErlane - Oct 25, 2023 Form 3 Insider Report for Catalent, Inc. (CTLT)

Role
Group President, Biologics
Signature
/s/ Amy Fallone, attorney-in-fact
Stock symbol
CTLT
Transactions as of
Oct 25, 2023
Transactions value $
$0
Form type
3
Date filed
11/2/2023, 09:17 PM
Next filing
Jul 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTLT Common Stock 19.6K Oct 25, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTLT Options to purchase Common Stock Oct 25, 2023 Common Stock 14.7K $45.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units, each representing the right to receive one share of Issuer's common stock as of the date of vesting, which is scheduled to occur in three equal annual installments beginning on September 25, 2024.
F2 The options vest and become exercisable in four equal annual installments beginning on September 25, 2024.